IVMED-60

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIVMED-60
Drug Alias NameAAV vector-based gene therapy (iVeena)IVMED-60
ClassificationBiologics
Mechanisms of ActionTEK receptor tyrosine kinase modulators
TargetsTEK receptor tyrosine kinase
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesiVeena LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesiVeena LLC
Active IndicationsN/A
Inactive IndicationsDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A